A health alert does not mean the same thing as epidemiological confirmation. In the north-west of the Democratic Republic of the Congo (DRC), the distinction is essential: reports of cases in North Ubangi do not match the available official data. The province named in verified reports is South Ubangi.
A western province, but not North Ubangi
The situation report published by the World Health Organization (WHO) on 8 October 2026 lists seven Congolese provinces affected by the outbreak: Bas-Uele, Haut-Uele, Ituri, North Kivu, South Kivu, South Ubangi and Tshopo. It does not mention North Ubangi. The WHO places the latest reported geographical spread in the Alimbongo health zone, in North Kivu, not in an eighth province.
This list is corroborated by figures sent by the Congolese health ministry to the Associated Press on 13 October: confirmed cases were then spread across seven provinces. An earlier report by the governor of South Ubangi and a former Congolese health minister also concerned that province, which borders the Central African Republic and the Republic of the Congo.
The claim of “two confirmed cases” in North Ubangi and an eighth province therefore cannot be presented as an established fact on the basis of verified information. It may stem from confusion between North Ubangi and South Ubangi, but none of the material consulted allows this to be asserted. This caveat does not rule out the circulation of a local alert: it means that its confirmation is not supported by the available figures.
An outbreak concentrated in the east, with spread westwards
Declared in May 2026, the outbreak is caused by the Bundibugyo virus, a strain of Ebola distinct from the better-known Zaire strain. As of 6 October, the WHO had recorded 8,728 confirmed cases and 4,205 confirmed deaths in the DRC. On 13 October, Congolese authorities reported 9,066 cases and 4,381 deaths. These figures correspond to different collection dates and should not be conflated.
Ituri remains the main epicentre. As of 6 October, the WHO counted 6,480 confirmed cases there, compared with 1,755 in North Kivu. However, the outbreak is not developing uniformly: some areas are seeing a decline, while others still have active transmission. The national figures therefore describe a crisis with distinct local dynamics, not identical spread in every province.
South Ubangi is particularly significant because of its position in the west of the country. The arrival of the virus in this province expands the area requiring vigilance beyond the eastern epicentres. It calls for surveillance adapted to movements between provinces and cross-border exchanges. It does not, by itself, mean that the virus has crossed the Central African border.
Testing and trust matter as much as borders
The response depends first on the rapid detection of infected people, the analysis of samples and the monitoring of their contacts. On 8 October, the WHO said that 23,741 of 29,535 contacts were being monitored as of 4 October, or 80.4%, below the operational target of 85%. Incomplete monitoring makes it harder to identify chains of transmission and delays interventions around new cases.
The burden is not evenly distributed. Health teams must reach remote communities, while residents may have to travel long distances to access care. Travel for work, trade or family ties also makes monitoring more complex. In towns and rural areas alike, deaths occurring outside treatment centres can limit opportunities for sampling and investigation.
This situation calls for precise public communication. A rumour about cases, a clinical suspicion and a confirmed laboratory result are not interchangeable. Confusing them can fuel concern or undermine trust in health authorities. Conversely, clearly stating what remains to be verified helps communities understand the measures being taken and cooperate with contact tracing.
There is currently no approved vaccine or specific treatment for Bundibugyo virus. Care relies in particular on supportive treatment and preventive measures: appropriate isolation, staff protection, testing, and safe and dignified burials. Ongoing trials and research must not be presented as meaning that a vaccine is immediately available.
A regional challenge that extends beyond the DRC
The cross-border dimension is already tangible. Uganda, which had reported cases linked to the outbreak, announced the end of its episode in August 2026. Kenya confirmed an imported case in early October in a person who had travelled from the DRC via Uganda. On 8 October, the WHO reported that the person had died in Kenya and that contact tracing had begun. This journey shows why coordination between neighbouring countries matters as much as surveillance in Congolese provinces.
For the Central African Republic, the Republic of the Congo and other neighbouring countries, the immediate challenge is to detect any suspected case rapidly and share health information, without imposing unjustified general restrictions. The WHO recommends stronger cooperation at borders and sustained surveillance. The priority, however, remains access to care and containing chains of transmission in areas where the virus is already circulating.
The next development to watch is therefore not an unconfirmed “eighth province”, but updated figures by health zone and the possible confirmation of new outbreaks by Congolese authorities and laboratories. In a mobile outbreak, accurate locations and figures are a direct component of the public health response.
Read the WHO situation report on the Bundibugyo outbreak in the DRC.
Read the 13 October figures provided by Congolese authorities.



